The pilot study for acupuncture stimulation effect on peripheral nervous system by measuring bio-signal

Daejeon Korean Medicine Hospital of Daejeon University0 个研究点目标入组 40 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1. Males and females aged 19-35 years;
•2. Individuals without any abnormal findings in blood pressure and thePhotoplethysmogram test (However, the criteria for abnormal findings are as follows: blood pressures measured twice and averaged in a sitting position, at intervals of at least 2 minutes after resting for at least 5 minutes; systolic blood pressure of 160 mmHg and over, or diastolic blood pressure of 100 mmHg and over; arrhythmia in the Photoplethysmogram test);
•3. Individuals who are clearly informed about the purpose and characteristics of the trial, and who agree to participate in it and sign the consent form.

•1. Individuals with autoimmune diseases such as asthma;
•2. Individuals with skin allergies such as atopy;
•3. Individuals with accompanying conditions that can affect the head, neck, and facial electromyogram (common cold, head injury, neck and jaw pain, toothache, or eye diseases);
•4. Individuals who have undergone surgery within the last one year or who have a serious medical history;
•5. Individuals with metal prostheses inserted in the body;
•6. Individuals currently on medication (oriental medicine and western medicine) or who plan to take medication during the clinical trial;
•7. Individuals who are judged unable not to maintain a sitting position at least for one hour;
•8. Individuals who are unsuitable for low-frequency electric stimulation due to systemic skin disorders or an allergy to electrode paste;
•9. Individuals who are judged unable to fill out the forms related to research performance
•10. Individuals with a medical history in psychiatry or with brain-related disorders;
•11. Individuals who are judged unable to participate in the experiment easily due to their biorhythms (lack of sleep; drinking within 72 hours);
•12. Individuals who are judged by the investigators to be unsuitable to participate in the clinical trial.

发起方

Daejeon Korean Medicine Hospital of Daejeon University